These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28224303)

  • 1. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tear-Film Osmolarity Changes Following Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
    Yuksel N; Akcay E; Ayan B; Duru N
    Curr Eye Res; 2017 Mar; 42(3):348-350. PubMed ID: 27419611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival cytologic features in anophthalmic patients wearing an ocular prosthesis.
    Kim JH; Lee MJ; Choung HK; Kim NJ; Hwang SW; Sung MS; Khwarg SI
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):290-5. PubMed ID: 18645434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
    Tıskaoğlu NS; Yazıcı A
    Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.
    Yazici A; Bulbul E; Yazici H; Sari E; Tiskaoglu N; Yanik B; Ermis S
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4425-9. PubMed ID: 26193918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctival bacterial flora in nasolacrimal duct obstruction and its changes after successful dacryocystorhinostomy surgery.
    Eshraghi B; Masoomian B; Izadi A; Abedinifar Z; Falavarjani KG
    Ophthalmic Plast Reconstr Surg; 2014; 30(1):44-6. PubMed ID: 24398486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival cicatrizing disease presenting with lacrimal obstruction.
    Satchi K; McNab AA
    Orbit; 2016 Dec; 35(6):321-323. PubMed ID: 27559621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is gastroesophageal reflux disease associated with primary acquired nasolacrimal duct obstruction?
    Mehta S; Ying GS; Hussain A; Harvey JT
    Orbit; 2018 Apr; 37(2):135-139. PubMed ID: 29040001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity.
    Murube J; Rivas L
    Eur J Ophthalmol; 2003 Mar; 13(2):115-27. PubMed ID: 12696629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
    Stahl U; Francis IC; Stapleton F
    Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
    Lee-Wing MW; Ashenhurst ME
    Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
    Tıskaoğlu NS; Yazıcı A
    Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of canalicular closure with endonasal dacryocystorhinostomy without intubation in primary nasolacrimal duct obstruction.
    Cannon PS; Chan W; Selva D
    Ophthalmology; 2013 Aug; 120(8):1688-92. PubMed ID: 23642376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry eye and decreased tear film stability in primary acquired nasolacrimal duct obstruction patients.
    Yu X; Wang K; Hu Y; Meng Z; Li J; Liu Y; Xiao L; Chen M; Li S; Shen Y; Chen R; Liang X
    Int Ophthalmol; 2024 Jun; 44(1):277. PubMed ID: 38916702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of primary acquired nasolacrimal duct obstruction.
    Kashkouli MB; Sadeghipour A; Kaghazkanani R; Bayat A; Pakdel F; Aghai GH
    Orbit; 2010 Feb; 29(1):11-5. PubMed ID: 20302403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of dye disappearance test and tear meniscus height in diagnosis and postoperative assessment of nasolacrimal duct obstruction.
    Roh JH; Chi MJ
    Acta Ophthalmol; 2010 May; 88(3):e73-7. PubMed ID: 20546233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
    Sweeney AR; Davis GE; Chang SH; Amadi AJ
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):20-25. PubMed ID: 27997463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.
    Ali MJ; Mishra DK; Bothra N
    Curr Eye Res; 2021 Aug; 46(8):1132-1136. PubMed ID: 33583297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric Evaluation of Bony Nasolacrimal Canal in a Caucasian Population with Primary Acquired Nasolacrimal Duct Obstruction: A Multidetector Computed Tomography Study.
    Bulbul E; Yazici A; Yanik B; Yazici H; Demirpolat G
    Korean J Radiol; 2016; 17(2):271-6. PubMed ID: 26957913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of fluorescein dye disappearance test in assessment of adults with nasolacrimal duct obstruction.
    Kashkouli MB; Mirzajani H; Jamshidian-Tehrani M; Pakdel F; Nojomi M; Aghaei GH
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):167-9. PubMed ID: 23503058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.